Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Insider Trading
Summary
Total Filings132
Unique Insiders41
Recent Filings
Insider | Role | Date |
|---|---|---|
| Bassler Bonnie L | director | Jan 7, 26 |
| Guarini Kathryn | director | Jan 2, 26 |
| SING GEORGE L | director | Jan 2, 26 |
| Zoghbi Huda Y | director | Jan 2, 26 |
| BROWN MICHAEL S | director | Jan 2, 26 |
| COLES N ANTHONY | director | Jan 2, 26 |
| RYAN ARTHUR F | director | Jan 2, 26 |
| GOLDSTEIN JOSEPH L | director | Jan 2, 26 |
| POON CHRISTINE A | director | Jan 2, 26 |
| Schenkein David P | director | Jan 2, 26 |
| Thompson Craig B. | director | Jan 2, 26 |
| YANCOPOULOS GEORGE | director, officer: Bd. Co-Chair, President & CSO | Dec 31, 25 |
| SCHLEIFER LEONARD S | director, officer: Bd. Co-Chair, President & CEO | Dec 31, 25 |
| McCourt Marion | officer: EVP Commercial | Dec 9, 25 |
| Van Plew Daniel P | officer: EVP & General Mgr, Industrial | Dec 9, 25 |
| MURPHY ANDREW J | officer: EVP Research | Dec 9, 25 |
| Pitofsky Jason | officer: VP Controller | Dec 8, 25 |
| LAROSA JOSEPH J | officer: EVP General Counsel and Secret | Dec 8, 25 |
| Fenimore Christopher R. | officer: EVP Finance CFO | Dec 8, 25 |
| STAHL NEIL | officer: EVP Research and Development | Dec 16, 24 |
| Fenimore Christopher R. | officer: SVP Finance & CFO | Dec 16, 24 |
| Pitofsky Jason | officer: Vice President, Controller | Feb 6, 24 |
| Landry Robert E | officer: EVP Finance CFO | Feb 2, 24 |
| Fenimore Christopher R. | officer: SVP Controller | Jan 23, 24 |
| Guarini Kathryn | director: | Sep 8, 23 |
| Schenkein David P | director: | Sep 8, 23 |
| SCHLEIFER LEONARD S | director, officer: President & CEO | May 15, 23 |
| VAGELOS P ROY | director | Apr 3, 23 |
| YANCOPOULOS GEORGE | director, officer: President and Chief Scientific | Mar 23, 23 |
| Tessier-Lavigne Marc | director | Jan 3, 23 |
| Thompson Craig B. | director: | Oct 3, 22 |
| Tessier-Lavigne Marc | director: | Sep 29, 22 |
| Bassler Bonnie L | director: | Sep 8, 22 |
| COLES N ANTHONY | director: | Sep 6, 22 |
| RYAN ARTHUR F | director: | Sep 6, 22 |
| POON CHRISTINE A | director: | Aug 9, 22 |
| SCHLEIFER LEONARD S | officer: President & CEO | Apr 5, 22 |
| GOLDSTEIN JOSEPH L | director: | Mar 30, 22 |
| VAGELOS P ROY | director: | Mar 30, 22 |
| BROWN MICHAEL S | director: | Mar 29, 22 |
| Zoghbi Huda Y | director: | Mar 16, 22 |
| Fenimore Christopher R. | officer: VP Controller | Dec 9, 20 |
| Van Plew Daniel P | officer: EVP & General Mgr Industrial O | Dec 9, 20 |
| McCourt Marion | officer: SVP Commercial | Dec 9, 20 |
| Sanofi | 10 percent owner | Jun 9, 20 |
| VAGELOS P ROY | director, officer: Chairman of the Board | May 21, 20 |
| YANCOPOULOS GEORGE | director, officer: President and CSO | Dec 12, 19 |
| LAROSA JOSEPH J | officer: SVP General Counsel and Secret | Dec 12, 18 |
| Landry Robert E | officer: SVP Finance & CFO | Dec 12, 18 |
| McCourt Marion | officer | Feb 12, 18 |
| BAKER CHARLES A | director | Jan 2, 18 |
| YANCOPOULOS GEORGE | director, officer: President & CSO | Dec 18, 17 |
| Terifay Robert J | officer: EVP Commercial | Dec 12, 17 |
| Aberman Michael S | officer: SVP Strategy Investor Relation | Jun 22, 17 |
| Fenimore Christopher R. | officer: VP, Controller | Mar 2, 17 |
| YANCOPOULOS GEORGE | director, officer: President Regeneron Laboratori | Dec 16, 16 |
| Powchik Peter | officer: SVP Clinical Development & Reg | Dec 16, 16 |
| McCorkle Douglas S | officer: VP Controller and Asst Treasur | Dec 29, 15 |
| Van Plew Daniel P | officer: SVP & General Mgr Industrial O | Dec 16, 15 |
| Terifay Robert J | officer: SVP Commercial | Dec 16, 15 |
| GILMAN ALFRED G | director | Aug 6, 15 |
| INGRAM ROBERT ALEXANDER | director | May 27, 15 |
| GOLDBERG MURRAY A | officer: SVP Administration & Asst Secr | Dec 16, 14 |
| STAHL NEIL | officer: SVP Research and Development S | Dec 16, 14 |
| Aberman Michael S | officer: VP Strategy and Investor Relat | Dec 16, 14 |
| INGRAM ROBERT ALEXANDER | director: | Apr 4, 14 |
| SHOOTER ERIC M | director | Feb 12, 14 |
| ROBERTS WILLIAM | officer: VP Reg Dev & Med Safety | Dec 31, 13 |
| YANCOPOULOS GEORGE | director, officer: Pres Regeneron Labs | Dec 16, 13 |
| Van Plew Daniel P | officer: SVP & Gen Mgr IOPS | Sep 18, 13 |
| Landry Robert E | officer: SVP Fin, Dep CFO | Sep 9, 13 |
| SCHLEIFER LEONARD S | director, officer: CEO & President | Sep 9, 13 |
| Landry Robert E | officer | Sep 9, 13 |
| GOLDBERG MURRAY A | officer: SVP Finance and Admin CFO and | Aug 1, 13 |
| McCorkle Douglas S | officer: VP Controller & Asst Treasurer | May 2, 13 |
| GOLDBERG MURRAY A | officer: SVP Finance and Admin CFO Trea | Jan 16, 13 |
| Powchik Peter | officer: SVP Clin Devel & Reg Affairs | Jan 9, 13 |
| YANCOPOULOS GEORGE | director, officer: EVP CSO Pres Regen Res Labs | Dec 19, 12 |
| STAHL NEIL | officer: SVP Res and Devel Sciences | Dec 17, 12 |
| GOLDBERG MURRAY A | officer: SVP Fin & Admin CFO Asst Secy | Dec 17, 12 |
| LAROSA JOSEPH J | officer: SVP Gen Counsel and Secretary | Dec 14, 12 |
| ROBERTS WILLIAM | officer: VP Regulat Dev & Med Safety | Dec 14, 12 |
| ROBERTS WILLIAM | officer: VP Regulatory Development and | Aug 24, 12 |
| YANCOPOULOS GEORGE | director, officer: EVP CSO Pres REGN Res Lab | Jun 27, 12 |
| STAHL NEIL | officer: SVP Res & Dev Sciences | Jun 19, 12 |
| YANCOPOULOS GEORGE | director, officer: EVP CSO President Regeneron Re | May 1, 12 |
| YANCOPOULOS GEORGE | director, officer: EVP, CSO & Pres, REGN Res Labs | Jan 5, 12 |
| LAROSA JOSEPH J | officer: SVP Gen Counsel & Secretary | Sep 1, 11 |
| Powchik Peter | officer: SVP Clinical Development | Aug 1, 11 |
| STAHL NEIL | officer: SVP Res and Dev Sciences | Apr 5, 11 |
| GOLDBERG MURRAY A | officer: SVP F&A, CFO, Treas & Asst Sec | Feb 18, 11 |
| ROBERTS WILLIAM | officer: VP Regul Devel & Med Safety | Jan 26, 11 |
| Van Plew Daniel P | officer: SVP & GM, Indust Ops&Prod Supp | Jan 18, 11 |
| SCHLEIFER LEONARD S | director, 10 percent owner, officer: CEO and President | Dec 14, 10 |
| Aberman Michael S | officer: VP, Strat and Invest Relations | Dec 14, 10 |
| YANCOPOULOS GEORGE | director, officer: EVP CSO & Pres Regn Res Labs | Dec 14, 10 |
| SANOFI-AVENTIS | 10 percent owner | Oct 13, 10 |
| KOLINSKI STUART | officer: SVP General Counsel and Secret | Jun 3, 10 |
| Dworkin Peter | officer: VP Investor Relations & Commun | Dec 18, 09 |
| SCHLEIFER LEONARD S | director, 10 percent owner, officer: Chief Exec Officer & President | Sep 13, 09 |
| ROBERTS WILLIAM | officer: VP Regul Devel & Clin Safety | Aug 12, 09 |
| GOLDBERG MURRAY A | officer: SVP F&A, CFO, Treas, & Ast Sec | Jan 2, 09 |
| KOLINSKI STUART | officer: SVP, Gen Counsel & Secretary | Dec 17, 08 |
| Terifay Robert J | officer: SVP, Commercial | Dec 17, 08 |
| STAHL NEIL | officer: SVP, Research & Devel Sciences | Dec 17, 08 |
| McCorkle Douglas S | officer: VP, Controller and Asst. Treas | Dec 17, 08 |
| ROBERTS WILLIAM | officer: VP, Regul Devel & Med Safety | Dec 17, 08 |
| Powchik Peter | officer: SVP, Clinical Development | Dec 17, 08 |
| YANCOPOULOS GEORGE | director, officer: EVP, CSO, & Pres Regn Res Labs | Dec 17, 08 |
| Van Plew Daniel P | officer: SVP & GM, Ind Ops & Prod Supp | Dec 17, 08 |
| GOLDBERG MURRAY A | officer: SVP Fin & Admin, CFO, & Treas | Dec 17, 07 |
| Van Plew Daniel P | officer: VP & Gn Mgr Ind Ops & Prod Sup | Dec 17, 07 |
| ROBERTS WILLIAM | officer: VP, Regul Devel & Clin Safety | Dec 17, 07 |
| Van Plew Daniel P | officer | Sep 7, 07 |
| RUPP RANDALL | officer: SVP, Manufuring Operations | Apr 13, 07 |
| Terifay Robert J | officer | Feb 26, 07 |
| KOLINSKI STUART | officer: VP, Gen Counsel & Secretary | Dec 18, 06 |
| ROBERTS WILLIAM | officer: VP, Regulatory Development | Dec 18, 06 |
| STAHL NEIL | officer: SVP, Therap & Clin Prog Dev | Dec 18, 06 |
| STAHL NEIL | officer: SVP, PreclinDevel & Biomol Sci | Feb 6, 06 |
| RUPP RANDALL | officer: SVP, Manuf & Process Sciences | Dec 19, 05 |
| NOVARTIS PHARMA AG | 10 percent owner | Nov 8, 05 |
| GULER HANS PETER | officer: VP Clinical Programs | Oct 8, 04 |
| SCHLEIFER LEONARD S | director, officer: Chief Exec Officer & President | Jan 4, 04 |
| GILMAN ALFRED G | director: | Dec 31, 03 |
| GULER HANS PETER | officer: VP, Clinical Sciences | Dec 15, 03 |
| RUPP RANDALL | officer: SVP, Manufacturing | Sep 15, 03 |
| STAHL NEIL | officer | Jul 9, 03 |
| GOLDBERG MURRAY A | officer | Jul 9, 03 |
| YANCOPOULOS GEORGE | director, officer: EVP, Chief Sci. Off. and Pres, | Jul 9, 03 |
| KOLINSKI STUART | officer | Jul 9, 03 |
| NOVARTIS INC | 10 percent owner: | May 13, 03 |